- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Consciousness Studies.
Displaying page 1 of 1.
EudraCT Number: 2013-001496-21 | Sponsor Protocol Number: LOC-2013 | Start Date*: 2013-06-18 |
Sponsor Name:Harry Scheinin | ||
Full Title: The Neural Mechanisms of Anesthesia and Human Consciousness | ||
Medical condition: No medical condition or disease involved. The study subjects are healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004982-10 | Sponsor Protocol Number: LOC-2016 | Start Date*: 2015-12-15 |
Sponsor Name:Harry Scheinin | ||
Full Title: The Neural Mechanisms of Anesthesia and Human Consciousness (Part 6) | ||
Medical condition: No medical condition or disease involved. The study subjects are healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001245-13 | Sponsor Protocol Number: 4LB-LEO-P | Start Date*: 2022-03-03 | ||||||||||||||||
Sponsor Name:4Living Biotech SAS | ||||||||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, two parallel groups, international multicenter trial to evaluate the effect of Plerixafor in acute respiratory failure related to COVID-19 (LEONARDO) | ||||||||||||||||||
Medical condition: Severe COVID-19 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) NL (Prematurely Ended) BG (Prematurely Ended) ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003889-42 | Sponsor Protocol Number: RN1001-319-1009 | Start Date*: 2008-08-26 | |||||||||||
Sponsor Name:Renovo | |||||||||||||
Full Title: A double blind, placebo controlled, randomised trial to investigate the efficacy of Juvista in the prevention or improvement of scar appearance when administered intradermally to approximated wound... | |||||||||||||
Medical condition: Patients undergoing scar revision surgery are left with scarring, which can vary from fine flat asymptomatic scars to hypertrophic scars. Studies show that these visible marks can cause emotional d... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016907-41 | Sponsor Protocol Number: fMRT-Nociception | Start Date*: 2012-09-10 |
Sponsor Name:Charité, Universitätsmedizin Berlin | ||
Full Title: Investigation of nociceptive and antinociceptive mechanisms under anesthesia using fMRI, EEG and noxious reflexes | ||
Medical condition: This is a CT including only healthy volunteers. The aim of the study is to investigate the effect of a commonly used anesthetic drug in clinical concentrations on nociceptive and antinociceptive me... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-000891-54 | Sponsor Protocol Number: REBOOT-II | Start Date*: 2016-11-28 |
Sponsor Name:Aging Research Center, Karolinska Institutet and Stockholm University | ||
Full Title: Effects of enhanced dopaminergic neurotransmission on working memory training efficiency in the healthy elderly - A prospective, single center, randomized, double blind, placebo controlled, paralle... | ||
Medical condition: No medical condition is under investigation. The project investigates normal age-related decline in intellectual abilities. | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-014344-11 | Sponsor Protocol Number: prot-001-2009 | Start Date*: 2010-06-02 | |||||||||||
Sponsor Name:Imperial College London | |||||||||||||
Full Title: Neuroprotective effects of hypothermia combined with inhaled xenon following perinatal asphyxia - the TOBY Xe trial | |||||||||||||
Medical condition: Neonatal asphyxial encephalopathy | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001590-29 | Sponsor Protocol Number: 022007 | Start Date*: 2007-07-06 | |||||||||||
Sponsor Name:Herz-, Thorax- und Gefäßchirurgische Anästhesie und Intensivmedizin | |||||||||||||
Full Title: Insulin aspart (NovoRapid®, Novo Nordisk) vs. human insulin (Actrapid®, Novo Nordisk) in intravenous treatment of high blood glucose concentrations in the ICU | |||||||||||||
Medical condition: Therapy of hyperglycemia by intravenously applied insulin is going to be investigated. Hyperglycemia is very common in hospitalized, critically ill patients, even if they have not previously had di... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-003783-27 | Sponsor Protocol Number: PN06-CLD-01001 | Start Date*: 2006-01-26 | |||||||||||
Sponsor Name:PAION Deutschland GmbH | |||||||||||||
Full Title: TOLERABILITY OF ENECADIN (INN) IN ACUTE ISCHEMIC STROKE TRIAL - TEST- PHASE IIA : A multicentre, double-blind, randomised, placebo-controlled, dose-escalating parallel- group study to investigate t... | |||||||||||||
Medical condition: acute ischemic stoke Based on the results of preclinical studies, enecadin is expected to play an important role in the treatment of acute ischemic stroke and to ameliorate the outcome and prognos... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Completed) AT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-002337-36 | Sponsor Protocol Number: 2007neuro07/R013630/S1 | Start Date*: 2008-06-06 | |||||||||||||||||||||
Sponsor Name:Salford Royal NHS Foundation Trust | |||||||||||||||||||||||
Full Title: An open-labelled study of the cerebrospinal fluid pharmacokinetics of intravenous Kineret® in patients with subarachnoid haemorrhage | |||||||||||||||||||||||
Medical condition: This is a pharmacokinetic study in patients who have had a Subarachnoid Haemorrhage and who have had an external ventricular drain inserted for clinical management reasons, must usually for the tre... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-000222-19 | Sponsor Protocol Number: H2020-PHC-18-2015-667224 | Start Date*: 2017-08-02 | ||||||||||||||||
Sponsor Name:University Hospital Tuebingen | ||||||||||||||||||
Full Title: Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome – a blinded randomized placebo-controlled parallel group multicenter trial for superiori... | ||||||||||||||||||
Medical condition: Perinatal Asphyxia, hypoxic-ischemic brain injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) NL (Ongoing) NO (Ongoing) ES (Ongoing) FI (Ongoing) EE (Ongoing) AT (Ongoing) BE (Ongoing) PT (Ongoing) IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000269-34 | Sponsor Protocol Number: GC2010 | Start Date*: 2021-03-20 | ||||||||||||||||||||||||||
Sponsor Name:Grifols Therapeutics LLC | ||||||||||||||||||||||||||||
Full Title: A Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of Anti-COVID-19 Immune Globulin (Human) 20% (C19-IG 20%) versus Placebo in Asymptomatic Ambulatory... | ||||||||||||||||||||||||||||
Medical condition: Subjects with laboratory-confirmed novel coronavirus (SARS-CoV-2) infection as determined by qualitative PCR (reverse transcriptase [RT]-PCR) that are asymptomathic | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-004271-22 | Sponsor Protocol Number: INSIGHTPROTOCOL006 | Start Date*: 2015-02-25 | |||||||||||
Sponsor Name:Regents of the University of Minnesota | |||||||||||||
Full Title: Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG) | |||||||||||||
Medical condition: Infleunza | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DK (Completed) ES (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-001476-11 | Sponsor Protocol Number: AL002-2 | Start Date*: 2020-11-12 | |||||||||||
Sponsor Name:Alector Inc. | |||||||||||||
Full Title: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AL002 IN PARTICIPANTS WITH EARLY ALZHEIMER’S DISEASE | |||||||||||||
Medical condition: Early Alzheimer’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) PL (Ongoing) DE (Ongoing) IT (Ongoing) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.